-Down to Earth Reasons behind the trend include high inventory levels, lower oil prices and renewed strength of the US dollar The Food Outlook report released on Thursday states that agricultural commodities are going through a period of lower prices and less volatility. After dramatic price rise from 2007 till early 2011, cereal and vegetable oil prices are now steady as well as on the decline, the biannual publication of the Food...

-Business Standard India’s growth in agriculture and allied activities has struggled to reach the targeted four per cent average a year in the first three years of the 12th five-year Plan because of a host of factors. The below-average farm growth is widely expected to deepen the crisis in the farm sector. In an interview with Sanjeeb Mukherjee, newly-appointed member of NITI Aayog and eminent agriculture economist Ramesh Chand  said over-reliance...

-Business Standard Cabinet note soon on Rs 1,800-cr investment over 5 years to boost sector, skills To push fish production, the Centre is formulating a programme to tap water reservoirs and neglected water bodies such as wetlands for breeding through modern technologies. The programme, part of Prime Minister Narendra Modi’s vision of a Blue Revolution, entails Rs 1,800 crore over the next five years, much lower than what was envisaged by a working...

-The Indian Express Government’s actions on the commodity reveals it is ignorant of how a market economy is run With each passing day this year, agriculture seems to be sagging and so is the Indian farmer. Deficit monsoon rains appear to be the trigger. Although rains offered some respite to Marathwada, the situation in India’s largest agri-state, Uttar Pradesh, has gone from bad to worse. Last year’s drought, with monsoon rains falling...

-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in...